GB0019599D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB0019599D0
GB0019599D0 GBGB0019599.0A GB0019599A GB0019599D0 GB 0019599 D0 GB0019599 D0 GB 0019599D0 GB 0019599 A GB0019599 A GB 0019599A GB 0019599 D0 GB0019599 D0 GB 0019599D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0019599.0A
Other versions
GB2365768A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Forschung GmbH
Original Assignee
Lilly Forschung GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Forschung GmbH filed Critical Lilly Forschung GmbH
Priority to GB0019599A priority Critical patent/GB2365768A/en
Publication of GB0019599D0 publication Critical patent/GB0019599D0/en
Priority to DK01906523T priority patent/DK1265612T3/en
Priority to AU34422/01A priority patent/AU3442201A/en
Priority to CN01804441A priority patent/CN1396828A/en
Priority to MXPA02007191A priority patent/MXPA02007191A/en
Priority to IL15047501A priority patent/IL150475A0/en
Priority to CA002399124A priority patent/CA2399124A1/en
Priority to BR0107958-1A priority patent/BR0107958A/en
Priority to TR2004/01436T priority patent/TR200401436T4/en
Priority to EP01906523A priority patent/EP1265612B1/en
Priority to HU0300709A priority patent/HUP0300709A3/en
Priority to SK1098-2002A priority patent/SK10982002A3/en
Priority to DZ013269A priority patent/DZ3269A1/en
Priority to AT01906523T priority patent/ATE267601T1/en
Priority to JP2001556474A priority patent/JP2003521518A/en
Priority to DE60103512T priority patent/DE60103512T2/en
Priority to PT01906523T priority patent/PT1265612E/en
Priority to EA200200831A priority patent/EA004708B1/en
Priority to NZ519727A priority patent/NZ519727A/en
Priority to ES01906523T priority patent/ES2220716T3/en
Priority to US10/181,379 priority patent/US6686365B2/en
Priority to SI200130113T priority patent/SI1265612T1/en
Priority to KR1020027009930A priority patent/KR20020081293A/en
Priority to PL01356705A priority patent/PL356705A1/en
Priority to CZ20022654A priority patent/CZ20022654A3/en
Priority to PCT/US2001/000648 priority patent/WO2001056575A1/en
Priority to MYPI20010433A priority patent/MY129450A/en
Priority to CO01007346A priority patent/CO5280222A1/en
Priority to PE2001000116A priority patent/PE20011223A1/en
Priority to ARP010100507A priority patent/AR027360A1/en
Priority to SV2001000301A priority patent/SV2002000301A/en
Publication of GB2365768A publication Critical patent/GB2365768A/en
Priority to NO20023379A priority patent/NO20023379L/en
Priority to HR20020636A priority patent/HRP20020636A2/en
Priority to HK03103377A priority patent/HK1052461A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GB0019599A 2000-02-04 2000-08-09 Stable liquid composition containing pemetrexed Withdrawn GB2365768A (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GB0019599A GB2365768A (en) 2000-08-09 2000-08-09 Stable liquid composition containing pemetrexed
PCT/US2001/000648 WO2001056575A1 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
PT01906523T PT1265612E (en) 2000-02-04 2001-01-23 PHARMACEUTICAL COMPOSITION UNDERSTANDING PEMETREXED CONVENIENTLY WITH MONOTIOGLICEROL L-CYSTEIN OR THYROGLYCOLIC ACID
NZ519727A NZ519727A (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol L-cysteine or thioglycolic acid
CN01804441A CN1396828A (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising Pemetrexed together with monothioglycerol L-cystein or thioglycolic acid
AU34422/01A AU3442201A (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
IL15047501A IL150475A0 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
ES01906523T ES2220716T3 (en) 2000-02-04 2001-01-23 PHARMACEUTICAL COMPOSITION THAT INCLUDES PEMETREXED WITH MONOTIOGLYCEROL, L-CYSTEINE AND THIOGLYCOLIC ACID.
BR0107958-1A BR0107958A (en) 2000-02-04 2001-01-23 Pharmaceutical composition containing pemetrexate together with l-cysteine monotrioglycerol or thioglycolic acid
TR2004/01436T TR200401436T4 (en) 2000-02-04 2001-01-23 Pharmaceutical composition containing pemetrexed with monothioglycerol, L-system or thioglycolic acid
EP01906523A EP1265612B1 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid
HU0300709A HUP0300709A3 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothiaglycerol l-cystein or thioglycolic acid
SK1098-2002A SK10982002A3 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol L-cystein or thioglycolic acid
DZ013269A DZ3269A1 (en) 2000-02-04 2001-01-23 PHARMACEUTICAL COMPOSITION COMPRISING PEMETREXED WITH MONOTHIOGLYCEROL, CYSTEIN L OR THIOGLYCOLIC ACID
AT01906523T ATE267601T1 (en) 2000-02-04 2001-01-23 PHARMACEUTICAL COMPOSITION CONTAINING PEMETREXED TOGETHER WITH MONOTHIOGLYCEROL, L-CYSTEINE OR THIOGLYCOLIC ACID
JP2001556474A JP2003521518A (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrex together with monothioglycerol, L-cysteine or thioglycolic acid
DE60103512T DE60103512T2 (en) 2000-02-04 2001-01-23 PHARMACEUTICAL COMPOSITION COMPRISING PEMETREXED WITH MONOTHIOGLYCEROL, L-CYSTEIN OR THIOGLYCOLIC ACID
DK01906523T DK1265612T3 (en) 2000-02-04 2001-01-23 A pharmaceutical composition comprising pemetrexed and monothioglycerol, l-cysteine or thioglycolic acid
EA200200831A EA004708B1 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
MXPA02007191A MXPA02007191A (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l cystein or thioglycolic acid.
CA002399124A CA2399124A1 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
US10/181,379 US6686365B2 (en) 2000-02-04 2001-01-23 Pharmaceutical composition
SI200130113T SI1265612T1 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid
KR1020027009930A KR20020081293A (en) 2000-02-04 2001-01-23 Pharmaceutical Composition Comprising Pemetrexed Together With Monothioglycerol L-Cystein or Thioglycolic Acid
PL01356705A PL356705A1 (en) 2000-02-04 2001-01-23 Pharmaceutical composition comprising pemetrexed together with monothioglycerol l-cystein or thioglycolic acid
CZ20022654A CZ20022654A3 (en) 2000-02-04 2001-01-23 Pharmaceutical composition containing Pemetrexed along with monothioglycerol, L-cysteine or thioglycolic acid
MYPI20010433A MY129450A (en) 2000-02-04 2001-01-31 Pharmaceutical composition
CO01007346A CO5280222A1 (en) 2000-02-04 2001-02-01 PHARMACEUTICAL COMPOSITION THAT PEMETREXED INCLUDES
PE2001000116A PE20011223A1 (en) 2000-02-04 2001-02-01 PHARMACEUTICAL COMPOSITION INCLUDING PEMETREXED AND AN ANTIOXIDANT SUCH AS MONOTHIOGLYCEROL, L-CYSTEINE AND THIOGLICOLIC ACID
ARP010100507A AR027360A1 (en) 2000-02-04 2001-02-02 PHARMACEUTICAL COMPOSITION
SV2001000301A SV2002000301A (en) 2000-02-04 2001-02-02 PHARMACEUTICAL COMPOSITION REF. Z-1032
NO20023379A NO20023379L (en) 2000-02-04 2002-07-12 A pharmaceutical composition comprising premetrexed together with monothioglycerol L-cysteine or thioglycolic acid
HR20020636A HRP20020636A2 (en) 2000-02-04 2002-07-26 Pharmaceutical composition comprising pemetrexed with monothioglycerol l-cystein or thioglycolic acid
HK03103377A HK1052461A1 (en) 2000-02-04 2003-05-13 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0019599A GB2365768A (en) 2000-08-09 2000-08-09 Stable liquid composition containing pemetrexed

Publications (2)

Publication Number Publication Date
GB0019599D0 true GB0019599D0 (en) 2000-09-27
GB2365768A GB2365768A (en) 2002-02-27

Family

ID=9897312

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0019599A Withdrawn GB2365768A (en) 2000-02-04 2000-08-09 Stable liquid composition containing pemetrexed

Country Status (1)

Country Link
GB (1) GB2365768A (en)

Also Published As

Publication number Publication date
GB2365768A (en) 2002-02-27

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
GB2358582B (en) Pharmaceutical compositions
HUP0204555A3 (en) Pharmaceutical composition
HUP0300582A3 (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HUP0400553A3 (en) Pharmaceutical compositions
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0031288D0 (en) Pharmaceutical compositions
GB0000062D0 (en) Pharmaceutical compositions
GB0001337D0 (en) Pharmaceutical compositions
GB0003929D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)